Thus, it cautious the strategy to overexpress molecules like MAGEA3 in pancreatic cancer cells, which will make them more immunogenic like in other cancers [73–76] but may have a serious negative consequence. This evidence concerns the gene MAGEA3 and familial pancreatic carcinoma.